OBJECTIVES: This review examines the burden and patterns of disease in systemic lupus erythematosus (SLE) and the influence and interactions of gender, ethnicity, age, and psychosocial attributes with respect to disease progression, focusing on issues relevant to clinical practice and research. METHODS: PubMed literature search complemented by review of bibliographies listed in identified articles. RESULTS: An increased risk among reproductive age women is clearly seen in African Americans in the United States. However, in other populations, a different pattern is generally seen, with the highest age-specific incidence rates occurring in women after age 40 years. The disease is 2 to 4 times more frequent, and more severe, among nonwhite populations around the world and tends to be more severe in men and in pediatric and late-onset lupus. SLE patients now experience a higher than 90% survival rate at 5 years. The less favorable survival experience of ethnic minorities is possibly related to socioeconomic status rather than to ethnicity per se, and adequate social support has been shown to be a protective factor, in general, in SLE patients. Discordance between physician and patient ratings of disease activity may affect quality of care. CONCLUSIONS: Our understanding of ways to improve outcomes in SLE patients could benefit from patient-oriented research focusing on many dimensions of disease burden. Promising research initiatives include the inclusion of community-based patients in longitudinal studies, use of self-assessment tools for rating disease damage and activity, and a focus on self-perceived disease activity and treatment compliance. (c) 2010 Elsevier Inc. All rights reserved.
OBJECTIVES: This review examines the burden and patterns of disease in systemic lupus erythematosus (SLE) and the influence and interactions of gender, ethnicity, age, and psychosocial attributes with respect to disease progression, focusing on issues relevant to clinical practice and research. METHODS: PubMed literature search complemented by review of bibliographies listed in identified articles. RESULTS: An increased risk among reproductive age women is clearly seen in African Americans in the United States. However, in other populations, a different pattern is generally seen, with the highest age-specific incidence rates occurring in women after age 40 years. The disease is 2 to 4 times more frequent, and more severe, among nonwhite populations around the world and tends to be more severe in men and in pediatric and late-onset lupus. SLEpatients now experience a higher than 90% survival rate at 5 years. The less favorable survival experience of ethnic minorities is possibly related to socioeconomic status rather than to ethnicity per se, and adequate social support has been shown to be a protective factor, in general, in SLEpatients. Discordance between physician and patient ratings of disease activity may affect quality of care. CONCLUSIONS: Our understanding of ways to improve outcomes in SLEpatients could benefit from patient-oriented research focusing on many dimensions of disease burden. Promising research initiatives include the inclusion of community-based patients in longitudinal studies, use of self-assessment tools for rating disease damage and activity, and a focus on self-perceived disease activity and treatment compliance. (c) 2010 Elsevier Inc. All rights reserved.
Authors: Sergio M A Toloza; América G Uribe; Gerald McGwin; Graciela S Alarcón; Barri J Fessler; Holly M Bastian; Luis M Vilá; Ruihua Wu; Yehuda Shoenfeld; Jeffrey M Roseman; John D Reveille Journal: Arthritis Rheum Date: 2004-12
Authors: Rebecca L Jump; Michael E Robinson; Ashley E Armstrong; Elena V Barnes; Kristin M Kilbourn; Hanno B Richards Journal: J Rheumatol Date: 2005-09 Impact factor: 4.666
Authors: J Calvo-Alén; G S Alarcón; R Campbell; M Fernández; J D Reveille; G S Cooper Journal: Rheumatology (Oxford) Date: 2005-06-14 Impact factor: 7.580
Authors: Jacques Boddaert; Du Le Thi Huong; Zahir Amoura; Bertrand Wechsler; Pierre Godeau; Jean-Charles Piette Journal: Medicine (Baltimore) Date: 2004-11 Impact factor: 1.889
Authors: S Rinaldi; A Doria; F Salaffi; M Ermani; L Iaccarino; A Ghirardello; S Zampieri; P Sarzi-Puttini; P F Gambari; G Perini Journal: Rheumatology (Oxford) Date: 2004-09-07 Impact factor: 7.580
Authors: Sudumpai Jarukitsopa; Deana D Hoganson; Cynthia S Crowson; Olayemi Sokumbi; Mark D Davis; Clement J Michet; Eric L Matteson; Hilal Maradit Kremers; Vaidehi R Chowdhary Journal: Arthritis Care Res (Hoboken) Date: 2015-05 Impact factor: 4.794
Authors: Michael R Edwards; Rujuan Dai; Bettina Heid; Thomas E Cecere; Deena Khan; Qinghui Mu; Catharine Cowan; Xin M Luo; S Ansar Ahmed Journal: Int Immunol Date: 2017-06-01 Impact factor: 4.823
Authors: Zhi-Wei Lai; Ryan Kelly; Thomas Winans; Ivan Marchena; Ashwini Shadakshari; Julie Yu; Maha Dawood; Ricardo Garcia; Hajra Tily; Lisa Francis; Stephen V Faraone; Paul E Phillips; Andras Perl Journal: Lancet Date: 2018-03-15 Impact factor: 79.321